5.58  -0.17 (-2.96%)		11-07 16:00
Open: 5.74 High: 5.8 Volume: 10,814		Pre. Close: 5.75 Low: 5.39 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	8.96	1-year :	10.61
Resists	First :	7.67	Second :	9.08
Pivot price	6.43
Supports	First :	5.38	Second :	4.48
MAs	MA(5) :	6.01	MA(20) :	6.57
	MA(100) :	6.27	MA(250) :	77.56
MACD	MACD :	-0.3	Signal :	-0.1
%K %D	K(14,3) :	10.9	D(3) :	8
RSI	RSI(14): 39.2
52-week	High :	2148	Low :	0.6

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ GCTK ] has closed above bottom band by 5.6%. Bollinger Bands are 50.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	5.84 - 5.89	5.89 - 5.93
Low:	5.28 - 5.35	5.35 - 5.39
Close:	5.65 - 5.77	5.77 - 5.84

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Tue, 04 Nov 2025
GlucoTrack Announces Special Shareholders Meeting for Equity Deal - The Globe and Mail

Mon, 03 Nov 2025
Glucotrack, Inc. Encourages Shareholders to Vote on Equity Purchase Agreement - TradingView

Mon, 03 Nov 2025
Glucotrack, Inc. Encourages Shareholders to Vote - Yahoo Finance

Tue, 14 Oct 2025
Lobbying Update: $50,000 of GLUCOTRACK INC. lobbying was just disclosed | GCTK Stock News - Quiver Quantitative

Sat, 13 Sep 2025
GlucoTrack Stock Soars on Sixth Borough Capital Fund Investment Commitment - StocksToTrade

Fri, 12 Sep 2025
Why Is Glucotrack Stock (GCTK) Up 150% Today? - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	-10 (M)
Shares Float	0 (M)
Held by Insiders	910690 (%)
Held by Institutions	842490 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	-1.536e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	441.2
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-178 %
Return on Equity (ttm)	-1 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.53
Qtrly Earnings Growth	-2 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0.01
Price to Sales	0
Price to Cash Flow	0

Dividend	57830
Forward Dividend	391900
Dividend Yield	1009250%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.